- Four-time NBA champion Stephen Curry has partnered with ophthalmic technology company Glaukos to launch the nationwide "Could It Be KC?" health awareness campaign.
- The educational initiative focuses on driving early detection of keratoconus (KC), a progressive eye disease that impairs vision.
- Curry kicked off the campaign in Oakland, California, reading an educational children's picture book to students and hosting a community pickup basketball session.
- The collaboration marks Glaukos’ first major celebrity ambassadorship, expanding the brand's outreach beyond medical clinics directly to families and young adults.
Ophthalmic medical technology firm Glaukos has teamed up with NBA superstar Stephen Curry to debut “Could It Be KC?”, a national campaign raising awareness for keratoconus. Keratoconus is a progressive condition where the cornea thins and gradually bulges into a cone shape, causing distorted sight.
The Golden State Warriors guard and Olympic gold medalist was diagnosed with keratoconus earlier in his professional career. Before doctors identified the condition, Curry frequently squinted and ignored recurring headaches, assuming nothing was seriously wrong with his vision.
Through this partnership, he aims to encourage families and young athletes to schedule regular eye examinations so doctors can catch symptoms early.
Curry inaugurated the campaign in Oakland, California, meeting with local students. During the event, he read aloud from an illustrated children’s book published by Glaukos that explains corneal health in simple terms, followed by an interactive pickup basketball clinic. Glaukos also introduced an online portal featuring symptom checklists and visual impairment simulators.
This campaign represents Curry’s first official collaboration with Glaukos. It also marks a pivotal strategic milestone for Glaukos, which historically directed its marketing strictly toward eye care physicians and medical conferences rather than consumer-facing celebrity campaigns. Curry serves as the company’s inaugural celebrity ambassador.
The deal further diversifies Stephen Curry’s brand footprint in 2026. Notable commercial moves this year include fronting a cameo in Google’s Pixel 11 ‘Reclaim the Moment’ spot and signing a landmark 10-year apparel pact with Li-Ning to scale his global retail reach.
Takeaways
Medical device and pharmaceutical companies often struggle to communicate complex health conditions to the general public without sounding overly technical.
Glaukos’ decision to enlist Stephen Curry bridges that gap naturally. As a historic shooter whose entire craft depends on elite depth perception and sight, Curry’s personal experience with keratoconus gives the campaign an undeniable layer of credibility.
Sharing his own story of brushing off headaches and squinting normalizes the diagnostic process for young people who might otherwise avoid mentioning vision issues to their parents or doctors.
Moving from traditional clinical messaging into community-centered outreach, complete with school readings and basketball clinics, shows how health brands can deliver life-changing medical awareness directly to everyday households.
How does knowing Stephen Curry manages a progressive corneal condition change your view of his shooting accuracy? Should youth athletic leagues and high schools include specialized corneal screenings as part of standard pre-season sports physicals?
